Patent Assignment
Reel/Frame 052548/0243
Assignment of Assignor's Interest
Recorded: 2020-05-01
Pages: 2
Assignor
ARS PHARMACEUTICALS INC.
Executed: 2020-04-30
Assignee
AEGIS THERAPEUTICS, LLC
3430 CARMEL MOUNTAIN ROAD, SUITE 300, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(3)
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Application:
16/420,034 →
Publication:
US 2019/0269780
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Application:
16/420,051 →
Publication:
US 2019/0269782
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 1, 2020
From: LOWENTHAL, RICHARD; SHAH, PRATIK; BELL, ROBERT G.
To: ARS PHARMACEUTICALS INC.
Reel/Frame 052548/0187 →
Assignment of Assignor's Interest
May 1, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 052548/0236 →
Security Interest
Aug 6, 2021
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057111/0242 →
Security Interest
Nov 14, 2024
From: AEGIS THERAPEUTICS, LLC
To: NEF ROYALTY SUB LLC
Reel/Frame 069261/0553 →
Release of Security Interest
Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →